Oseni 12.5 mg / 15 mg Oral Tablet
RxNorm 1368409
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1368409 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Oseni 12.5 mg / 15 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Alogliptin 12.5 mg / pioglitazone 15 mg Oral Tablet [Oseni]
(Atom ID: 5079479)
PSN
Prescribable Name (PSN):
Oseni 12.5 mg / 15 mg Oral Tablet
(Atom ID: 6370708)
SY
Synonym (SY):
Oseni 12.5/15 (as alogliptin benzoate 17 mg / pioglitazone hydrochloride 16.53 mg) Oral Tablet
(Atom ID: 5070864)
SY